載入...
Immune-based Therapy Clinical Trials in Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related mortality and continues to increase. Current standard of care for patients with HCC only provides limited therapeutic benefit. Development of innovative strategies is urgently needed. Experience with immunotherapy in HCC is...
Na minha lista:
| 發表在: | J Clin Cell Immunol |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4750497/ https://ncbi.nlm.nih.gov/pubmed/26877890 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4172/2155-9899.1000376 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|